The influence of the preventive treatment by levels of s-PECAM-1 and s-VCAM-1 among pregnant woman with gestational endotheliopathy

dc.contributor.author	Konkov, D. G.	en
dc.date.accessioned	2017-11-05T16:16:33Z
dc.date.available	2017-11-05T16:16:33Z
dc.date.issued	2015
dc.identifier.citation	Konkov D. G. The influence of the preventive treatment by levels of s-PECAM-1 and s-VCAM-1 among pregnant woman with gestational endotheliopathy / D. G. Konkov // Science and Innovation in the XXI Century. Collection of Conference Papers of International Scientific-Practical Conference, 13-14 Apr. 2015, London (United Kingdom). – u-conferences.org / Centre for Scientific and Practical Studies, 2015. - P. 6-8.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/1277
dc.description.abstract	The author presents the results of studying the influence of the preventive treatment by the levels of soluble forms of vascular cell adhesion molecule-1 (s-VCAM-1) and platelet endothelial cell adhesion moleculae-1 (s-PECAM-1) in 47 patients with gestational endotheliopathy (GE), 18 healthy pregnant controls by using an enzyme-linked immunosorbent assay (ELISA).	en
dc.language.iso	en	en
dc.subject	gestational endotheliopathy	en
dc.subject	arginine	en
dc.subject	pecam-1	en
dc.subject	VCAM-1	en
dc.title	The influence of the preventive treatment by levels of s-PECAM-1 and s-VCAM-1 among pregnant woman with gestational endotheliopathy	en
dc.type	Article	en